| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.09 |